GHK-CU

GHK-CU 100MG

Manufacturer: Unique Pharma
Package: 100 mg/vial
Common Names: GHK-Cu, Copper Tripeptide-1, Glycyl-L-Histidyl-L-Lysine Copper Complex

Info: GHK-Cu is a naturally occurring copper-binding tripeptide composed of glycine, histidine, and lysine. It has attracted significant interest in scientific research due to its interaction with copper-dependent biological processes and its potential role in pathways associated with tissue remodeling, extracellular matrix regulation, cellular signaling, and skin physiology. GHK-Cu is widely studied in the context of regenerative, dermatological, and cellular research.

Effects

Tissue Remodeling Research: GHK-Cu has been investigated for its potential influence on biological processes involved in tissue remodeling, extracellular matrix organization, and cellular repair. Research has examined its relationship with collagen and other structural components of connective tissue.

Skin and Collagen Research: GHK-Cu is particularly well known for research concerning skin physiology and collagen-related pathways. Experimental studies have explored its interaction with fibroblast activity, extracellular matrix production, skin elasticity, and mechanisms associated with maintaining tissue structure.

Dosage Range and Duration of Use

GHK-Cu 100 mg (100 mg/vial): Each vial contains 100 mg of GHK-Cu in lyophilized form. GHK-Cu remains a research compound, and there is no universally established or officially approved dosage regimen for general clinical use. In experimental research protocols involving parenteral administration, subcutaneous dosing typically ranges from 1 mg to 2 mg per day (or approximately 2 mg to 5 mg injected 3 to 5 times per week) for cycles lasting 4 to 8 weeks, often followed by an off-cycle period of equal duration. For topical research applications, protocols generally utilize formulations concentrated at 1% to 3% applied once or twice daily over 6 to 12 weeks to observe tissue remodeling and skin regeneration effects. 

Side Effects

The complete safety profile of GHK-Cu has not been established for all routes of administration and research applications. Potential reactions may depend on exposure, formulation, administration method, individual characteristics, and other substances used concurrently. When administered topically, research involving copper peptides has generally focused on local skin responses, while other routes require appropriate medical or research oversight.

Post-Cycle Therapy

GHK-Cu is not an anabolic steroid, androgenic compound, or testosterone-suppressing anabolic agent. It therefore does not require conventional post-cycle therapy (PCT) protocols associated with anabolic steroid use. As a research peptide, its use should nevertheless remain within an appropriate medical or scientific framework.

Storage:

Store lyophilized GHK-Cu according to the manufacturer's storage specifications and protect the vial from excessive heat, moisture, and direct exposure to light. After reconstitution, storage requirements and stability may depend on the diluent, concentration, preparation method, and manufacturer's instructions.